<DOC>
	<DOCNO>NCT00709449</DOCNO>
	<brief_summary>A number common eye diseases age-related macular degeneration glaucoma associate ocular perfusion abnormality . Although well recognize much possibility improve blood flow posterior pole eye disease . For many year , moxaverine use therapy perfusion abnormality brain , heart extremity . This base direct vasodilatatory effect drug , also rheological property red blood cell . In recent study investigator show intravenous moxaverine increase choroidal blood flow healthy young subject . The present study aim investigate , whether moxaverine also improve blood flow diseased eye systemic administration .</brief_summary>
	<brief_title>An Open Study Comparing Effects Moxaverine Ocular Blood Flow Patients With Age- Related Macular Degeneration , Primary Open Angle Glaucoma Healthy Control Subjects</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Moxaverine</mesh_term>
	<mesh_term>Papaverine</mesh_term>
	<criteria>Men woman age 50 year Ametropia less 6 diopter anisometropia less 2 diopter Clear nonlenticular ocular medium AMD patient : Patients nonexudative AMD Visual acuity study eye &gt; 20/60 Glaucoma patient : Unilateral bilateral primary open angle glaucoma At least 3 reliable visual field testing Treated intraocular pressure &lt; 21 mmHg , Visual field mean deviation MD &lt; 10 ( Humphrey 302 ) Healthy control subject : Age , gender sex match two patient group , Matched regard smoke habit two patient group No observable eye disease History presence gastrointestinal , liver kidney disease , condition know interfere distribution , metabolism excretion study drug Blood donation previous 3 week Abuse alcoholic beverage drug , participation clinical trial 3 week precede study Known diabetes mellitus Presence ocular pathology interferes aim present study Intraocular surgery within last 3 week Hypersensitivity moxaverine Acute gastric bleeding , massive cerebral hemorrhage relate stroke</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Age-related macular degeneration</keyword>
	<keyword>Glaucoma</keyword>
</DOC>